Robinson A
Department of Pathology and Laboratory Medicine, Hartford Hospital, Connecticut 06102.
Clin Microbiol Rev. 1994 Apr;7(2):185-99. doi: 10.1128/CMR.7.2.185.
There is virtually universal consensus that the health care system in the United States is too expensive and that costs need to be limited. Similar to health care costs in general, clinical laboratory expenditures have increased rapidly as a result of increased utilization and inflationary trends within the national economy. Economic constraints require that a compromise be reached between individual welfare and limited societal resources. Public pressure and changing health care needs have precipitated both subtle and radical laboratory changes to more effectively use allocated resources. Responsibility for excessive laboratory use can be assigned primarily to the following four groups: practicing physicians, physicians in training, patients, and the clinical laboratory. The strategies to contain escalating health care costs have ranged from individualized physician education programs to government intervention. Laboratories have responded to the fiscal restraints imposed by prospective payment systems by attempting to reduce operational costs without adversely impacting quality. Although cost containment directed at misutilization and overutilization of existing services has conserved resources, to date, an effective cost control mechanism has yet to be identified and successfully implemented on a grand enough scale to significantly impact health care expenditures in the United States.
几乎普遍达成的共识是,美国的医疗保健系统成本过高,需要加以限制。与总体医疗保健成本类似,由于利用率提高和国民经济中的通胀趋势,临床实验室支出也迅速增加。经济限制要求在个人福利和有限的社会资源之间达成妥协。公众压力和不断变化的医疗保健需求促使实验室发生了微妙而激进的变化,以更有效地利用分配的资源。实验室过度使用的责任主要可归咎于以下四类群体:执业医师、实习医师、患者和临床实验室。控制不断攀升的医疗保健成本的策略从个性化的医师教育项目到政府干预不等。实验室通过试图在不负面影响质量的情况下降低运营成本,来应对前瞻性支付系统施加的财政限制。尽管针对现有服务的滥用和过度使用进行成本控制节省了资源,但迄今为止,尚未找到一种有效的成本控制机制并在足够大的规模上成功实施,以显著影响美国的医疗保健支出。